Haleos Labs' (NSE:HALEOSLABS) Shareholders Have More To Worry About Than Only Soft Earnings

Simply Wall St · 2d ago

Haleos Labs Limited's (NSE:HALEOSLABS) stock showed strength, with investors undeterred by its weak earnings report. While shareholders may be willing to overlook soft profit numbers, we believe that they should also be taking into account some other factors which may be cause for concern.

earnings-and-revenue-history
NSEI:HALEOSLABS Earnings and Revenue History November 19th 2026

A Closer Look At Haleos Labs' Earnings

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

Haleos Labs has an accrual ratio of 0.23 for the year to September 2026. Unfortunately, that means its free cash flow fell significantly short of its reported profits. Even though it reported a profit of ₹129.5m, a look at free cash flow indicates it actually burnt through ₹612m in the last year. We saw that FCF was ₹262m a year ago though, so Haleos Labs has at least been able to generate positive FCF in the past. The good news for shareholders is that Haleos Labs' accrual ratio was much better last year, so this year's poor reading might simply be a case of a short term mismatch between profit and FCF. As a result, some shareholders may be looking for stronger cash conversion in the current year.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Haleos Labs.

Our Take On Haleos Labs' Profit Performance

Haleos Labs didn't convert much of its profit to free cash flow in the last year, which some investors may consider rather suboptimal. Therefore, it seems possible to us that Haleos Labs' true underlying earnings power is actually less than its statutory profit. But on the bright side, its earnings per share have grown at an extremely impressive rate over the last three years. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Haleos Labs at this point in time. Be aware that Haleos Labs is showing 5 warning signs in our investment analysis and 3 of those don't sit too well with us...

Today we've zoomed in on a single data point to better understand the nature of Haleos Labs' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.